Wiley Matthew T.
- SEC CIK
- 0001759703
In the past year, 1 open-market sale filing worth $129.1K and no purchases.
Current role at each company
- DFTX Definium Therapeutics, Inc.Chief Commercial Officeras of Sep 14, 2026
- BTAIQ BioXcel Therapeutics, Inc.Other: See Remarksas of Apr 1, 2025
- YARW Yarrow Bioscience, Inc.Chief Commercial Officeras of Jul 2, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $129.1K
- 1 filing
- Net
- −$129.1K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Wiley Matthew T. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
DFTX Definium Therapeutics, Inc.
Chief Commercial Officer1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 26, 2026 (view filing) | Jun 25 | 1 day | Wiley Matthew T.Chief Commercial Officer | SSale | −2.87K | $45.03 | −$129.1K | −1.6%174.6K after | 10b5-1 |
BTAIQ BioXcel Therapeutics, Inc.
Other: See Remarks4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 3, 2024 (view filing) | Oct 3 | Same day | Wiley Matthew T.Chief Commercial Officer | SSale | −6.27K | $0.55 | −$3.45K | −24.8%19.0K after | 10b5-1 |
| Sep 17, 2024 (view filing) | Sep 16 | 1 day | Wiley Matthew T.Chief Commercial Officer | SSale | −215 | $0.69 | −$148.35 | −5.1%4.03K after | 10b5-1 |
| Jun 18, 2024 (view filing) | Jun 17 | 1 day | Wiley Matthew T.Chief Commercial Officer | SSale | −244 | $1.26 | −$307.44 | −6.5%3.50K after | From original |
| Apr 8, 2024 (view filing) | Apr 4 | 4 days | Wiley Matthew T.CHIEF COMMERCIAL OFFICER | SSale | −1.01K | $2.64 | −$2.66K | −25.2%2.99K after | 10b5-1 |